I have no connection other than exercising my right as a shareholder and emailing questions to the CEO. To which I must say answers everyone promptly and professionally. I suggest others exercise this right and many would not feel so negative. For instance yesterday I pleaded with him to engage in just a little bit of hype and salesmanship.....just a little bit. He writes back today the following
"I always take the view that biotech is a long-term investment, with its prospects determined by the scientific quality of the data," Emphasis added
So there you have it as I have always suspected, they are simply not going to indulge in hype, maybes or blue sky ann to lift the SP other than letting the data speak for itself.
Those poster who want a stellar rising SP on hot air and rat studies .....you know where to go. Those that want to invest based on human results.......stay the course and start buying up. Because show time is just around the corner in 2018
